Cargando…

Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population

BACKGROUND: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated with depression and anxiety, since they can be responsible for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovilla-Zárate, Carlos, Juárez-Rojop, Isela, Peralta Jimenez, Yesenia, Jiménez, María Antonia, Vázquez, Silvia, Bermúdez-Ocaña, Deysi, Ramón-Frías, Teresa, Genis Mendoza, Alma D., García, Sherezada Pool, Narváez, Lilia López
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356343/
https://www.ncbi.nlm.nih.gov/pubmed/22629339
http://dx.doi.org/10.1371/journal.pone.0036887
_version_ 1782233547188207616
author Tovilla-Zárate, Carlos
Juárez-Rojop, Isela
Peralta Jimenez, Yesenia
Jiménez, María Antonia
Vázquez, Silvia
Bermúdez-Ocaña, Deysi
Ramón-Frías, Teresa
Genis Mendoza, Alma D.
García, Sherezada Pool
Narváez, Lilia López
author_facet Tovilla-Zárate, Carlos
Juárez-Rojop, Isela
Peralta Jimenez, Yesenia
Jiménez, María Antonia
Vázquez, Silvia
Bermúdez-Ocaña, Deysi
Ramón-Frías, Teresa
Genis Mendoza, Alma D.
García, Sherezada Pool
Narváez, Lilia López
author_sort Tovilla-Zárate, Carlos
collection PubMed
description BACKGROUND: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated with depression and anxiety, since they can be responsible for premature morbidity, mortality, risk of developing comorbidities, complications, suffering of patients, as well as escalation of costs. We studied the frequency of depression and anxiety in Mexican outpatients with type 2 diabetes and identified the risk factors for depression and anxiety. METHODS AND FINDINGS: We performed a study in 820 patients with type 2 diabetes. The prevalence of depression and anxiety was estimated using the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale, respectively. We calculated the proportions for depression and anxiety and, after adjusting for confounding variables, we performed multivariate analysis using multiple logistic regressions to evaluate the combined effect of the various factors associated with anxiety and depression among persons with type 2 diabetes. The rates for depression and anxiety were 48.27% (95% CI: 44.48–52.06) and 55.10% (95% CI: 51.44–58.93), respectively. Occupation and complications in diabetes were the factors associated with anxiety, whereas glucose level and complications in diabetes were associated with depression. Complications in diabetes was a factor common to depression and anxiety (p<0.0001; OR 1.79, 95% CI 1.29–2.4). CONCLUSIONS: Our findings demonstrate that a large proportion of diabetic patients present depression and/or anxiety. We also identified a significant association between complications in diabetes with depression and anxiety. Interventions are necessary to hinder the appearance of complications in diabetes and in consequence prevent depression and anxiety.
format Online
Article
Text
id pubmed-3356343
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33563432012-05-24 Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population Tovilla-Zárate, Carlos Juárez-Rojop, Isela Peralta Jimenez, Yesenia Jiménez, María Antonia Vázquez, Silvia Bermúdez-Ocaña, Deysi Ramón-Frías, Teresa Genis Mendoza, Alma D. García, Sherezada Pool Narváez, Lilia López PLoS One Research Article BACKGROUND: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated with depression and anxiety, since they can be responsible for premature morbidity, mortality, risk of developing comorbidities, complications, suffering of patients, as well as escalation of costs. We studied the frequency of depression and anxiety in Mexican outpatients with type 2 diabetes and identified the risk factors for depression and anxiety. METHODS AND FINDINGS: We performed a study in 820 patients with type 2 diabetes. The prevalence of depression and anxiety was estimated using the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale, respectively. We calculated the proportions for depression and anxiety and, after adjusting for confounding variables, we performed multivariate analysis using multiple logistic regressions to evaluate the combined effect of the various factors associated with anxiety and depression among persons with type 2 diabetes. The rates for depression and anxiety were 48.27% (95% CI: 44.48–52.06) and 55.10% (95% CI: 51.44–58.93), respectively. Occupation and complications in diabetes were the factors associated with anxiety, whereas glucose level and complications in diabetes were associated with depression. Complications in diabetes was a factor common to depression and anxiety (p<0.0001; OR 1.79, 95% CI 1.29–2.4). CONCLUSIONS: Our findings demonstrate that a large proportion of diabetic patients present depression and/or anxiety. We also identified a significant association between complications in diabetes with depression and anxiety. Interventions are necessary to hinder the appearance of complications in diabetes and in consequence prevent depression and anxiety. Public Library of Science 2012-05-18 /pmc/articles/PMC3356343/ /pubmed/22629339 http://dx.doi.org/10.1371/journal.pone.0036887 Text en Tovilla-Zárate et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tovilla-Zárate, Carlos
Juárez-Rojop, Isela
Peralta Jimenez, Yesenia
Jiménez, María Antonia
Vázquez, Silvia
Bermúdez-Ocaña, Deysi
Ramón-Frías, Teresa
Genis Mendoza, Alma D.
García, Sherezada Pool
Narváez, Lilia López
Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title_full Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title_fullStr Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title_full_unstemmed Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title_short Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population
title_sort prevalence of anxiety and depression among outpatients with type 2 diabetes in the mexican population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356343/
https://www.ncbi.nlm.nih.gov/pubmed/22629339
http://dx.doi.org/10.1371/journal.pone.0036887
work_keys_str_mv AT tovillazaratecarlos prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT juarezrojopisela prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT peraltajimenezyesenia prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT jimenezmariaantonia prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT vazquezsilvia prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT bermudezocanadeysi prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT ramonfriasteresa prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT genismendozaalmad prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT garciasherezadapool prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation
AT narvaezlilialopez prevalenceofanxietyanddepressionamongoutpatientswithtype2diabetesinthemexicanpopulation